Showing results (41-50 of 52) with videos related to
Sort By:
Pageof 6
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 28, 2019
Incidence and distribution of UroSEEK gene panel in a multi-institutional cohort of bladder urothelial carcinomaMarie-Lisa Eich, Maria Del Carmen Rodriguez Pena, Simeon U Springer, et al.Histopathology|October 31, 2025
Comparison of glass-based and whole-slide image-based grade assignment for clear-cell and papillary renal cell carcinoma: a multi-cohort, international reproducibility studyJulian Westerdorf, Maria Tretiakova, Richard Weiten, et al.Virchows Archiv : an International Journal of Pathology|June 10, 2017
Spectrum of genetic mutations in de novo PUNLMP of the urinary bladderMaria Del Carmen Rodriguez Pena, Aline C Tregnago, Marie-Lisa Eich, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 8, 2023
Artificial Intelligence-Based Tool for Tumor Detection and Quantitative Tissue Analysis in Colorectal SpecimensJohanna Griem, Marie-Lisa Eich, Simon Schallenberg, et al.Journal of Cancer Research and Clinical Oncology|July 14, 2023
Digital droplet PCR-based quantification of ccfHPV-DNA as liquid biopsy in HPV-driven cervical and vulvar cancerFabinshy Thangarajah, Jana Busshoff, Janina Salamon, et al.NPJ Precision Oncology|August 15, 2023
An international multi-institutional validation study of the algorithm for prostate cancer detection and Gleason gradingYuri Tolkach, Vlado Ovtcharov, Alexey Pryalukhin, et al.JCI Insight|May 22, 2024
Blocking the angiopoietin-2-dependent integrin β-1 signaling axis abrogates small cell lung cancer invasion and metastasisLydia Meder, Charlotte Isabelle Orschel, Christoph Julius Otto, et al.JCI Insight|July 19, 2022
ARID1A-deficient bladder cancer is dependent on PI3K signaling and sensitive to EZH2 and PI3K inhibitorsHasibur Rehman, Darshan S Chandrashekar, Chakravarthi Balabhadrapatruni, et al.Nature Communications|December 8, 2025
ERBB2 signaling drives immune cell evasion and resistance against immunotherapy in small cell lung cancerLydia Meder, Charlotte I Orschel, Cyrielle L Bouchez, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2026
ADC target profiling in NSCLC: Generalizable AI separates TROP-2 and cMET phenotypesPhilipp Anders, Marvin Sextro, Katja Lingelbach, et al.Pageof 6